Am J Transplant, Volume 19, Suppl 3 Archives - Page 192 of 214 - ATC Abstracts

2019 American Transplant Congress
Long-Term Influence of Arteriosclerosis in Kidney Grafts Proven by a Zero-Hour Biopsy
Y. Kakuta¹, M. Okumi¹, T. Kanzawa¹, K. Unagami², H. Ishida¹, K. Tanabe¹
¹Urology, Tokyo Women's Medical University, Tokyo, Japan, ²Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan
*Purpose: Histopathological assessment of kidney grafts by zero-hour biopsies adds unique information concerning organ quality that is not available on clinical grounds. The most prevalent…
2019 American Transplant Congress
Unhinged or Unselfish: A Deep Dive into Non-Directed Donors
J. Verbesey¹, M. Williams², S. Ghasemian¹, A. Bacigalupo¹, A. Gilbert¹, G. Vranic¹, B. Javaid¹, M. Cooper¹, A. Marsh²
¹MedStar Georgetown Transplant Institute, Washington, DC, ²Georgetown University Hospital, Washington, DC
*Purpose: Non-directed donors (NDDs) bring great excitement to living donor centers. However, evaluating NDD motivation can be challenging. Our group compared the altruist (NDD) with…
2019 American Transplant Congress
An Interesting Case of Proteinuria in Living Kidney Donor
A. Yadav, W. Maley, P. Singh
Thomas Jefferson University, Philadelphia, PA
*Purpose: Evaluation for proteinuria is vital to assess suitability for live kidney donation. Living unrelated donor with orthostatic proteinuria was evaluated. This case highlights importance…
2019 American Transplant Congress
Incisional Ventral Hernia Repair (IVHR) in Post Liver Transplant Recipients (OLT) through a Robotic-Assisted Intervention (RAI): Initial Single-Center Experience
A. Mejia, C. G. Fasola, A. Stegall
Liver Transplantation, Methodist Dallas Medical Center, Dallas, TX
*Purpose: To analyze the outcome of IVH repairs in liver transplant recipients using a minimally invasive technique.*Methods: From 2016 to 2018, we analyzed the IVHR…
2019 American Transplant Congress
Impact of Hepatitis C Viremia on Post-Transplant Diabetes Mellitus Development in Liver Transplant Recipients
K. Klein¹, J. Nelson², B. Crowther¹, C. Guerra³, E. Kincaide¹, K. V. Speeg⁴, N. Alkhouri⁵, R. Hall¹
¹University Health System, The University of Texas at Austin, College of Pharmacy, Pharmacotherapy Division, Austin, TX, The University of Texas Health Science Center at San Antonio, San Antonio, TX, ²University Health System, San Antonio, TX, ³The University of Texas Health Science Center at San Antonio, University of the Incarnate Word Feik School of Pharmacy, San Antonio, TX, ⁴University Health System, The University of Texas Health Science Center at San Antonio, San Antonio, TX, ⁵University Health System, The University of Texas Health Science Center at San Antonio, Texas Liver Institute, San Antonio, TX
*Purpose: Compare incidence of post-transplant diabetes mellitus (PTDM) in hepatitis C virus (HCV) patients with and without viremia at the time of orthotopic liver transplantation…
2019 American Transplant Congress
Clinical Outcomes of Living versus Deceased Donor Liver Transplantation for Primary Sclerosing Cholangitis: A Multicenter 15 Year Experience
O. Y. Mousa¹, K. D. Watt¹, J. K. Heimbach², A. P. Keaveny³, J. E. Eaton¹, D. M. Harnois³, B. Taner³, E. J. Carey⁴, A. A. Moss⁴, C. B. Rosen⁵, T. Taner⁵
¹Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, ²Department of Surgery, Mayo Clinic, Rochester, MN, ³Department of Transplant, Mayo Clinic, Jacksonville, FL, ⁴Department of Transplant, Mayo Clinic, Scottsdale, AZ, ⁵Department of Transplant, Mayo Clinic, Rochester, MN
*Purpose: MELD-based allocation is known to reduce access to deceased donor liver transplantation (DDLT) for patients with primary sclerosing cholangitis (PSC). Living donor liver transplantation(LDLT)…
2019 American Transplant Congress
Impact of a Liver Waitlist Candidate LDLT Educational Outreach Program on Referrals and Outcomes of Donor Evaluation
C. Saroli Palumbo, J. Batisti, R. Batra, J. Dopico, D. Haakinson, L. Hughes, M. Joyce, S. Klein, S. Kulkarni, D. Mulligan, P. Narayanan, M. Schilsky, R. Tomlin, K. Ventura, S. Emre, A. Liapakis
Yale, New Haven, CT
*Purpose: Challenges to identify suitable candidates for living donor liver transplantation (LDLT) include low donor acceptance, recipient & provider team reluctance to pursue LDLT. A…
2019 American Transplant Congress
Comparison of Tacrolimus or Cyclosporine Combined with Methotrexate for Graft versus Host Disease Prophylaxis after Allogeneic Hematopoietic Cell Transplantation: A Meta-Analysis
M. Chen, B. Huang, Y. Zhang, W. Ju, X. He
Transplant Center, Sun Yat-sen University, Guangzhou, China
*Purpose: After patients received hematopoietic stem cell transplantation (HSCT) ,both cyclosporine (CsA) and tacrolimus (TAC) in combination with methotrexate (MTX) have been recommended as standard…
2019 American Transplant Congress
mTOR Inhibitors Enhance Antitumor Activity of Liver Resident NK Cells
J. Saparbay, Y. Tanaka, A. Seidakhmetov, H. Ohdan
Gastroenterology and transplant Surgery, Hiroshima University, Hiroshima, Japan
*Purpose: The immunosuppressive regimen currently used after organ transplantation reduces adaptive components. Therefore, the innate immune cells play pivotal roles in immune surveillance and defense…
2019 American Transplant Congress
Endothelial Cells Do Not Regulate Expression of CD46, CD55 and CD59 in the Presence of Anti-HLA Class I and 11 Antibodies
A. Babu¹, T. Pham², M. Hamdorf², V. Jucaud², M. Everly², S. Daga³, D. Mitchell⁴
¹Transplant Institute, Henry Ford Hospitals, Detroit, MI, ²Terasaki Research Institute, Los Angeles, CA, ³University of Warwick, Coventry, United Kingdom, ⁴Medical Sciences, University of Warwick, Coventry, United Kingdom
*Purpose: Anti-HLA antibodies, both pre-formed and de novo are associated with worse graft survival. Complement activation is an important mechanism of antibody mediated immunological injury.…